Bank of New York Mellon’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-28,412
| Closed | -$84K | – | 4358 |
|
|
2016
Q3 | $84K | Sell |
28,412
-4,804
| -14% | -$14.2K | ﹤0.01% | 4076 |
|
|
2016
Q2 | $49K | Sell |
33,216
-101,800
| -75% | -$150K | ﹤0.01% | 4176 |
|
|
2016
Q1 | $499K | Buy |
135,016
+1,254
| +0.9% | +$4.64K | ﹤0.01% | 3437 |
|
|
2015
Q4 | $1.35M | Sell |
133,762
-32,159
| -19% | -$325K | ﹤0.01% | 2958 |
|
|
2015
Q3 | $2.26M | Sell |
165,921
-9,910
| -6% | -$135K | ﹤0.01% | 2654 |
|
|
2015
Q2 | $3.34M | Sell |
175,831
-15,751
| -8% | -$299K | ﹤0.01% | 2597 |
|
|
2015
Q1 | $5.01M | Buy |
191,582
+8,461
| +5% | +$221K | ﹤0.01% | 2315 |
|
|
2014
Q4 | $3.83M | Buy |
183,121
+7,339
| +4% | +$154K | ﹤0.01% | 2451 |
|
|
2014
Q3 | $5.87M | Buy |
175,782
+10,463
| +6% | +$349K | ﹤0.01% | 2215 |
|
|
2014
Q2 | $5.31M | Buy |
165,319
+6,227
| +4% | +$200K | ﹤0.01% | 2294 |
|
|
2014
Q1 | $7.35M | Sell |
159,092
-14,513
| -8% | -$670K | ﹤0.01% | 2091 |
|
|
2013
Q4 | $12.3M | Buy |
173,605
+8,825
| +5% | +$626K | ﹤0.01% | 1753 |
|
|
2013
Q3 | $14.1M | Buy |
164,780
+20,595
| +14% | +$1.77M | ﹤0.01% | 1620 |
|
|
2013
Q2 | $9.13M | Buy |
+144,185
| New | +$9.13M | ﹤0.01% | 1836 |
|